Cargando…
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer related to asbestos exposure. The tumor microenvironment content, particularly the presence of macrophages, was described as crucial for the development of the disease. This work aimed at studying the involvement of the...
Autores principales: | Blondy, Thibaut, d'Almeida, Sènan Mickael, Briolay, Tina, Tabiasco, Julie, Meiller, Clément, Chéné, Anne-Laure, Cellerin, Laurent, Deshayes, Sophie, Delneste, Yves, Fonteneau, Jean-François, Boisgerault, Nicolas, Bennouna, Jaafar, Grégoire, Marc, Jean, Didier, Blanquart, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319783/ https://www.ncbi.nlm.nih.gov/pubmed/32581053 http://dx.doi.org/10.1136/jitc-2019-000182 |
Ejemplares similares
-
Brain-derived neurotrophic factor, a new soluble biomarker for malignant pleural mesothelioma involved in angiogenesis
por: Smeele, Patrick, et al.
Publicado: (2018) -
Oncolytic virotherapy for human malignant mesothelioma: recent advances
por: Boisgerault, Nicolas, et al.
Publicado: (2015) -
Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
por: Bensaid, Douae, et al.
Publicado: (2018) -
High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma
por: Delaunay, Tiphaine, et al.
Publicado: (2020) -
Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma
por: Denis, Iza, et al.
Publicado: (2014)